CTSO vs SO · $28.8M cap vs P/E 22, rev $29.55B
Cytosorbents Crp (CTSO) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
CTSO does not have a complete income-statement cache yet.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
CTSO currently screens at market cap $28.8M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the CTSO and SO stock pages for the full models.
Not investment advice.